Nitric Oxide Impairs Normoxic Degradation of HIF-1α by Inhibition of Prolyl Hydroxylases
Open accessThe DOI matches its Crossref record; 61 of the 63 references it cites were found in a registry or an index.
Abstract
Hypoxia inducible factor-1 (HIF-1) is the master regulator of metabolic adaptation to hypoxia. It is appreciated that HIF-1alpha accumulation is achieved under normoxic conditions by e.g., nitric oxide. We determined molecular mechanisms of HIF-1alpha accumulation under the impact of S-nitrosoglutathione (GSNO). In human embryonic kidney cells GSNO provoked nuclear accumulation of HIF-1alpha. This appeared unrelated to gene transcription and protein translation, thus pointing to inhibition of HIF-1alpha degradation. Indeed, GSNO as well as the hypoxia mimic CoCl2 decreased ubiquitination of HIF-1alpha and GSNO-induced HIF-1alpha failed to coimmunoprecipitate with pVHL (von Hippel Lindau protein). Considering that HIF-1alpha-pVHL interactions require prolyl hydroxylation of HIF-1alpha, we went on to demonstrate inhibition of HIF-1alpha prolyl hydroxylases (PHDs) by GSNO. In vitro HIF-1alpha-pVHL interactions revealed that GSNO dose-dependently inhibits PHD activity but not the interaction of a synthetic peptide resembling the hydroxylated oxygen-dependent degradation domain of HIF-1alpha with pVHL. We conclude that GSNO-attenuated prolyl hydroxylase activity accounts for HIF-1alpha accumulation under conditions of NO formation during normoxia and that PHD activity is subject to regulation by NO.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In line with earlier findings (Metzen et al., 2003), we observed that LPS-triggered HIF1 a accumulation was partially reduced in DC treated with the inducible nitric oxide (NO) synthase 2 ( Nos2 ) inhibitor L-NIL (Figures 2L and S2D).”
From Ferritin-Mediated Iron Sequestration Stabilizes Hypoxia-Inducible Factor-1α upon LPS Activation in the Presence of Ample Oxygen (2015) · cites this paper as Metzen et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · cited 2×
“The impact of GSNO on PHD activity was tested in a GalDBD-HIF-1 549–582-pVHL in vitro interaction assay, performed as described previously (Jaakkola et al., 2001).”
BackgroundMethodThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · cited 2×
“The requirement of pVHL for HIF-1 degradation is underscored in cells that do not contain a functional pVHL, which leads to high levels of HIF-1 in normoxia (Maxwell et al., 1999; Krieg et al., 2000; Clifford et al., 2001).”
BackgroundHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 2×
“In normoxia HIF-1α is hydroxylated at Pro564 and Pro402 which is required for pVHL binding (Ivan et al., 2001; Jaakkola et al., 2001; Masson et al., 2001; Yu et al., 2001).”
BackgroundEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Self-citationBiochemistry of nitric oxide and its redox-activated forms
Stamler, J. S., Singel, D. J., & Loscalzo, J. (1992) · Science · doi:10.1126/science.1281928 · Cited by 2,744
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549 · cited 1×
“The human enzymes have been termed prolyl hydroxylase domain containing protein 1, 2, and 3 (PHD1, PHD2, and PHD3; Epstein et al., 2001) or HIF1 prolyl hydroxylase 1, 2, and 3 (Bruick and McKnight, 2001).”
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113 · cited 1×
“Consequently, HIF-1 is polyubiquitinated and degraded by the 26S proteasome system, thus accounting for its low normoxic level of expression (Salceda and Caro, 1997; Huang et al., 1998; Kallio et al., 1999).”
BackgroundPurification and Characterization of Hypoxia-inducible Factor 1
Wang, G. L., & Semenza, G. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1230 · Cited by 2,073 · cited 1×
“HIF-1 is composed of the two basic helix-loop-helix-Per-Arnt-Sim (bHLH-PAS) proteins HIF-1 and the aryl hydrocarbon receptor nuclear translocator (ARNT), also known as HIF-1 (Wang and Semenza, 1995).”
BackgroundChandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000
Salceda, S., & Caro, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22642 · Cited by 1,674 · cited 1×
“Consequently, HIF-1 is polyubiquitinated and degraded by the 26S proteasome system, thus accounting for its low normoxic level of expression (Salceda and Caro, 1997; Huang et al., 1998; Kallio et al., 1999).”
BackgroundOhh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577 · cited 1×
“In normoxia HIF-1 is bound to the von Hippel Lindau protein (pVHL) (Maxwell et al., 1999; Hon et al., 2002; Min et al., 2002), which is the substrate recognizing component of an E3 ubiquitin ligase complex (Cockman et al., 2000; Ohh et al., 2000; Tanimoto et al., 2000).”
BackgroundAsparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558 · cited 1×
“The pGal-HIF-1727– 826 plasmid was generously provided by Dr. D. Lando and Dr. M.L. Whitelaw ( Lando et al., 2002b ).”
MethodLando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L., & Bruick, R. K. (2002) · Genes & Development · doi:10.1101/gad.991402 · Cited by 1,550 · cited 2×
“The latter enzyme hydroxylates Asn803 of HIF-1 , which attenuates the C-terminal transactivation domain (CTAD) of the transcription factor by abrogating the recruitment of transcriptional coactivators such as CBP/p300 (Hewitson et al., 2002; Lando et al., 2002a).”
BackgroundMethodProteasome inhibitors: valuable new tools for cell biologists.
Lee, D. H., & Goldberg, A. L. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01346-4 · Cited by 1,474 · cited 4×
“1-HA-VHL encoding HA-tagged full-length pVHL. Cells were subjected to 1% hypoxia or stimulated with 100 M CoCl2 or 1 mM GSNO for 4 h and subsequently exposed to 10 M MG132 for 1 h. Cells were scraped off the dishes and collected.”
MethodInfluentialMahon, P. C., Hirota, K., & Semenza, G. L. (2001) · Genes & Development · doi:10.1101/gad.924501 · Cited by 1,385
Wenger, R. H. (2002) · The FASEB Journal · doi:10.1096/fj.01-0944rev · Cited by 1,135 · cited 4×
“In hypoxia, HIF-1 is strikingly induced, translocates to the nucleus, and dimerizes with HIF-1 to form HIF-1, which binds to hypoxiaresponsive elements (HRE) in regulatory regions of an impressive array of target genes involved in angiogenesis, erythropoiesis, vasomotor control, and energy metabolism as well as in cel…”
BackgroundInfluentialHIF-1 and tumor progression: pathophysiology and therapeutics
Semenza, G. L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02317-1 · Cited by 1,060 · cited 3×
“The heterodimeric transcription factor hypoxia inducible factor-1 (HIF-1) plays a central role in adaptation to decreased oxygen availability (Semenza, 2002; Wenger, 2002; Brüne and Zhou, 2003).”
BackgroundCockman, M. E., Masson, N., Mole, D. R., Jaakkola, P., Chang, G.-W., Clifford, S. C., Maher, E. R., Pugh, C. W., Ratcliffe, P. J., & Maxwell, P. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002740200 · Cited by 1,050
Gao, X., Wu, G., Gu, X., Fu, L., & Mei, C. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000355743 · Cited by 1,035
Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5197 · Cited by 1,014 · cited 1×
“In normoxia HIF-1 is hydroxylated at Pro564 and Pro402, which is required for pVHL binding (Ivan et al., 2001; Jaakkola et al., 2001; Masson et al., 2001; Yu et al., 2001).”
BackgroundSemenza, G. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00518-9 · Cited by 935 · cited 1×
“In hypoxia, formation of active HIF-1 occurs through inhibition of the human oxygen-dependent HIF-1 prolyl hydroxylases (PHD1, PHD2, PHD3) by lack of oxygen (Semenza, 2001; Oehme et al., 2002).”
BackgroundTanimoto, K., Makino, Y., Pereira, T., & Poellinger, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4298 · Cited by 928 · cited 2×
“In normoxia HIF-1 is bound to the von Hippel Lindau protein (pVHL) (Maxwell et al., 1999; Hon et al., 2002; Min et al., 2002), which is the substrate recognizing component of an E3 ubiquitin ligase complex (Cockman et al., 2000; Ohh et al., 2000; Tanimoto et al., 2000).”
BackgroundHIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation
Yu, F., White, S. B., Zhao, Q., & Lee, F. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181341498 · Cited by 796 · cited 1×
“In normoxia HIF-1 is hydroxylated at Pro564 and Pro402, which is required for pVHL binding (Ivan et al., 2001; Jaakkola et al., 2001; Masson et al., 2001; Yu et al., 2001).”
BackgroundStructure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling
Min, J.-H., Yang, H., Ivan, M., Gertler, F., Kaelin, W. G., & Pavletich, N. P. (2002) · Science · doi:10.1126/science.1073440 · Cited by 765
Regulation of the Hypoxia-inducible Transcription Factor 1α by the Ubiquitin-Proteasome Pathway
Kallio, P. J., Wilson, W. J., O'Brien, S., Makino, Y., & Poellinger, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6519 · Cited by 754 · cited 1×
“Consequently, HIF-1 is polyubiquitinated and degraded by the 26S proteasome system, thus accounting for its low normoxic level of expression (Salceda and Caro, 1997; Huang et al., 1998; Kallio et al., 1999).”
BackgroundStructural basis for the recognition of hydroxyproline in HIF-1α by pVHL
Hon, W.-C., Wilson, M. I., Harlos, K., Claridge, T. D. W., Schofield, C. J., Pugh, C. W., Maxwell, P. H., Ratcliffe, P. J., Stuart, D. I., & Jones, E. Y. (2002) · Nature · doi:10.1038/nature00767 · Cited by 751
Hewitson, K. S., McNeill, L. A., Riordan, M. V., Tian, Y.-M., Bullock, A. N., Welford, R. W., Elkins, J. M., Oldham, N. J., Bhattacharya, S., Gleadle, J. M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200273200 · Cited by 719 · cited 1×
“The latter enzyme hydroxylates Asn803 of HIF-1α which attenuates the C-terminal transactivation domain (CTAD) of the transcription factor by abrogating the recruitment of transcriptional coactivators such as CBP/p300 (Hewitson et al., 2002; Lando et al., 2002a).”
BackgroundHsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway
Isaacs, J. S., Jung, Y.-J., Mimnaugh, E. G., Martinez, A., Cuttitta, F., & Neckers, L. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204733200 · Cited by 663 · cited 2×
“However, recently, a pVHL- and oxygen-independent HIF-1 degradation pathway has been reported (Isaacs et al., 2002).”
BackgroundIvan, M., Haberberger, T., Gervasi, D. C., Michelson, K. S., Günzler, V., Kondo, K., Yang, H., Sorokina, I., Conaway, R. C., Conaway, J. W., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192342099 · Cited by 561 · cited 8×
“Accumulation of active HIF-1 results from inhibition of the HIF-1 hydroxylases PHD1, PHD2, PHD3, and FIH-1.”
BackgroundInfluentialHegg, E. L., & Jr, L. Q. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-1-00625.x · Cited by 521
Interleukin-1β and Tumor Necrosis Factor- Stimulate DNA Binding of Hypoxia-Inducible Factor-1
Hellwig-Bürgel, T., Rutkowski, K., Metzen, E., Fandrey, J., & Jelkmann, W. (1999) · Blood · doi:10.1182/blood.v94.5.1561 · Cited by 475
Self-citationI. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation
Grisham, M. B., Jourd’Heuil, D., & Wink, D. A. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.2.g315 · Cited by 450 · cited 1×
“NO is known to interact with iron (II) heme- or nonhemecontaining proteins (Grisham et al., 1999).”
BackgroundKimura, H., Weisz, A., Kurashima, Y., Hashimoto, K., Ogura, T., D'Acquisto, F., Addeo, R., Makuuchi, M., & Esumi, H. (2000) · Blood · doi:10.1182/blood.v95.1.189 · Cited by 439
Crystal structure of isopenicillin N synthase is the first from a new structural family of enzymes
Roach, P. L., Clifton, I. J., Fülöp, V., Harlos, K., Barton, G. J., Hajdu, J., Andersson, I., Schofield, C. J., & Baldwin, J. E. (1995) · Nature · doi:10.1038/375700a0 · Cited by 420 · cited 2×
“, 1985) or to isopenicillin N synthase (Roach et al., 1995).”
BackgroundHart, T. W. (1985) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)98368-0 · Cited by 398
Krieg, M., Haas, R., Brauch, H., Acker, T., Flamme, I., & Plate, K. H. (2000) · Oncogene · doi:10.1038/sj.onc.1203938 · Cited by 396 · cited 1×
“The requirement of pVHL for HIF-1 degradation is underscored in cells that do not contain a functional pVHL, which leads to high levels of HIF-1 in normoxia (Maxwell et al., 1999; Krieg et al., 2000; Clifford et al., 2001).”
BackgroundClifford, S. C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1029 · Cited by 373
Inhibition of Hypoxia-inducible Factor 1 Activation by Carbon Monoxide and Nitric Oxide
Huang, L. E., Willmore, W. G., Gu, J., Goldberg, M. A., & Bunn, H. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.9038 · Cited by 291 · cited 2×
“Initial observations suggested that NO inhibits hypoxia-induced HIF-1 stabilization and HIF-1 transcriptional activation (Liu et al., 1998; Sogawa et al., 1998; Huang et al., 1999).”
BackgroundAccumulation of HIF-1α under the influence of nitric oxide
Sandau, K. B., Fandrey, J., & Brüne, B. (2001) · Blood · doi:10.1182/blood.v97.4.1009 · Cited by 265 · cited 8×
“The plasmid pGLEPOHRE, provided by Dr. T. Kietzmann (University of Göttingen, Göttingen, Germany), harbors three erythropoietin hypoxia-responsive elements (HRE) in front of the SV40 promoter and was described previously (Sandau et al., 2001b).”
BackgroundResultInfluentialSelf-citationRole of Prolyl Hydroxylation in Oncogenically Stabilized Hypoxia-inducible Factor-1α
Chan, D. A., Sutphin, P. D., Denko, N. C., & Giaccia, A. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206922200 · Cited by 264 · cited 1×
“Using a hydroxyproline-specific HIF- antibody, it has been demonstrated very recently that oncogenes such as v-Src and RasV12 stabilize HIF-1 in normoxia by attenuating prolyl hydroxylation (Chan et al., 2002).”
BackgroundKimura, H., Weisz, A., Ogura, T., Hitomi, Y., Kurashima, Y., Hashimoto, K., D'Acquisto, F., Makuuchi, M., & Esumi, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008398200 · Cited by 259 · cited 2×
“…or enhanced endogenous NO formation by inducible NO-synthase or NO formation in a coculture system under normoxic conditions provoked HIF-1 stabilization, HIF-1 DNA-binding, and activation of downstream target gene expression (Kimura et al., 2001; Sandau et al., 2001a, 2001b; Zhou et al., 2003).”
BackgroundO'Rourke, J. F., Tian, Y.-M., Ratcliffe, P. J., & Pugh, C. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2060 · Cited by 242 · cited 2×
“1-HA-VHL, and pGalluc (O’Rourke et al., 1999) were kindly provided by Dr.”
MethodInhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia
Sogawa, K., Numayama-Tsuruta, K., Ema, M., Abe, M., Abe, H., & Fujii-Kuriyama, Y. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7368 · Cited by 224 · cited 2×
“Initial observations suggested that NO inhibits hypoxia-induced HIF-1 stabilization and HIF-1 transcriptional activation (Liu et al., 1998; Sogawa et al., 1998; Huang et al., 1999).”
BackgroundRole of hydrogen peroxide in hypoxia-induced erythropoietin production
Fandrey, J., Frede, S., & Jelkmann, W. (1994) · Biochemical Journal · doi:10.1042/bj3030507 · Cited by 223 · cited 2×
“…e.g., dihydrofluorescein, seem to indicate enhanced ROS generation in hypoxia (Chandel et al., 2000), other methods such as the detection of hydrogen peroxide using the chemiluminescent dye luminol suggest that ROS production is rather decreased in hypoxia (Fandrey et al., 1994; Vaux et al., 2001).”
MethodSelf-citationLiu, Y., Christou, H., Morita, T., Laughner, E., Semenza, G. L., & Kourembanas, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.15257 · Cited by 220 · cited 2×
“Initial observations suggested that NO inhibits hypoxia-induced HIF-1 stabilization and HIF-1 transcriptional activation (Liu et al., 1998; Sogawa et al., 1998; Huang et al., 1999).”
BackgroundSandau, K. B., Zhou, J., Kietzmann, T., & Brüne, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107689200 · Cited by 213 · cited 5×
“The plasmid pGLEPOHRE, provided by Dr. T. Kietzmann (University of Göttingen, Göttingen, Germany), harbors three erythropoietin hypoxia-responsive elements (HRE) in front of the SV40 promoter and was described previously (Sandau et al., 2001b).”
BackgroundResultInfluentialSelf-citationThe von Hippel–Lindau tumor suppressor protein
Ivan, M., & Kaelin, W. G. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00152-0 · Cited by 211
Vaux, E. C., Metzen, E., Yeates, K. M., & Ratcliffe, P. J. (2001) · Blood · doi:10.1182/blood.v98.2.296 · Cited by 199 · cited 2×
“…e.g., dihydrofluorescein, seem to indicate enhanced ROS generation in hypoxia (Chandel et al., 2000), other methods such as the detection of hydrogen peroxide using the chemiluminescent dye luminol suggest that ROS production is rather decreased in hypoxia (Fandrey et al., 1994; Vaux et al., 2001).”
MethodSelf-citationPalmer, L. A., Gaston, B., & Johns, R. A. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12688-0 · Cited by 193 · cited 4×
“In addition, a modulatory role of nitric oxide (NO) emerged (Kimura et al., 2000; Palmer et al., 2000; Sandau et al., 2000, 2001a).”
BackgroundResultInfluentialOehme, F., Ellinghaus, P., Kolkhof, P., Smith, T. J., Ramakrishnan, S., Hütter, J., Schramm, M., & Flamme, I. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00862-8 · Cited by 165 · cited 1×
“In hypoxia, formation of active HIF-1 occurs through inhibition of the human oxygen-dependent HIF-1 prolyl hydroxylases (PHD1, PHD2, PHD3) by lack of oxygen (Semenza, 2001; Oehme et al., 2002).”
BackgroundArciero, D. M., Orville, A. M., & Lipscomb, J. D. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38681-7 · Cited by 162 · cited 2×
“This may be exemplified by spectroscopic studies when NO directly binds to the ferrous ion in protocatechuate 4,5-dioxygenase and catechol 2,3-dioxygenase (Arciero et al., 1985) or to isopenicillin N synthase (Roach et al.”
BackgroundHow oxygen makes its presence felt: Figure 1.
Kaelin, W. G. (2002) · Genes & Development · doi:10.1101/gad.1003602 · Cited by 150
Induction of Hypoxia-Inducible-Factor 1 by Nitric Oxide Is Mediated via the PI 3K Pathway
Sandau, K. B., Faus, H., & Brüne, B. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3789 · Cited by 140 · cited 1×
“In addition, a modulatory role of nitric oxide (NO) emerged (Kimura et al., 2000; Palmer et al., 2000; Sandau et al., 2000, 2001a).”
BackgroundSelf-citationActivated pp60c-Src Leads to Elevated Hypoxia-inducible Factor (HIF)-1α Expression under Normoxia
Karni, R., Dor, Y., Keshet, E., Meyuhas, O., & Levitzki, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206141200 · Cited by 116 · cited 2×
“It has been observed that active HIF-1 can be induced by the oncogene pp60(c-Src) in normoxia by enhanced HIF-1α synthesis (Karni et al., 2002).”
BackgroundThe Role of Nitric Oxide (NO) in Stability Regulation of Hypoxia Inducible Factor-1α (HIF-1α)
Brune, B., & Zhou, J. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457746 · Cited by 111 · cited 2×
“…(sodium nitroprusside) and is evident in distinct cells such as pig LLC-PK1 cells, human glioblastoma cells, human hepatoma cells, bovine pulmonary artery endothelial cells, or HEK293 cells, thus arguing against a NO donor or cell type–specific response (for references, see Brüne and Zhou, 2003).”
BackgroundSelf-citationThe pVHL-HIF-1 system: A key mediator of oxygen homeostasis
Maxwell, P., Pugh, C. W., & Ratcliffe, P. J. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-3401-0_24 · Cited by 100 · cited 1×
“…binds to hypoxiaresponsive elements (HRE) in regulatory regions of an impressive array of target genes involved in angiogenesis, erythropoiesis, vasomotor control, and energy metabolism as well as in cell survival decisions (for references, see Maxwell et al., 2001; Wenger, 2002; Zhu et al., 2002).”
BackgroundBrüne, B., Mohr, S., & Meßmer, U. K. (1995) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/bfb0048263 · Cited by 82 · cited 2×
“In vitro HIF-1α-pVHL interactions under the impact of GSNO It is established that NO or NO derived species may cause posttranslational protein modifications (Stamler et al., 1992; Brüne et al., 1996).”
BackgroundSelf-citationNO and TNF-α released from activated macrophages stabilize HIF-1α in resting tubular LLC-PK1 cells
Zhou, J., Fandrey, J., Schümann, J., Tiegs, G., & Brüne, B. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00294.2002 · Cited by 81 · cited 2×
“…or enhanced endogenous NO formation by inducible NO-synthase or NO formation in a coculture system under normoxic conditions provoked HIF-1 stabilization, HIF-1 DNA-binding, and activation of downstream target gene expression (Kimura et al., 2001; Sandau et al., 2001a, 2001b; Zhou et al., 2003).”
BackgroundSelf-citationWang, F., Sekine, H., Kikuchi, Y., Takasaki, C., Miura, C., Heiwa, O., Shuin, T., Fujii‐Kuriyama, Y., & Sogawa, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00729-5 · Cited by 69 · cited 10×
“Because PHDs and FIH-1 hydroxylate HIF-1 in an oxygen-dependent manner, they function as oxygen sensors in vivo.”
BackgroundInfluentialDetecting and responding to hypoxia
Zhu, H., Jackson, T., & Bunn, H. F. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_1.3 · Cited by 66 · cited 2×
“In hypoxia, HIF-1 is strikingly induced, translocates to the nucleus, and dimerizes with HIF-1 to form HIF-1, which binds to hypoxiaresponsive elements (HRE) in regulatory regions of an impressive array of target genes involved in angiogenesis, erythropoiesis, vasomotor control, and energy metabolism as well as in cel…”
Background
Cited by
Protein S-nitrosylation: Purview and parameters
Hess, D. T., Matsumoto, A., Kim, S.-O., Marshall, H. E., & Stamler, J. S. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1569 · Cited by 2,153
“Subsequently, it was reported that GSNO decreased the binding of HIFα and VHL, and therefore HIFα ubiquitylation, and that this effect was correlated with the ability of GSNO to inhibit the activity of prolyl hydoxylases in vitro”
BackgroundOxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
“Several studies of the HIF/hydroxylase pathway have shown both apparent inhibition of hydroxylation and activation of HIF transcriptional activity by different NO donor”
BackgroundRedox regulation of cell survival
Trachootham, D., Lu, W., Ogasawara, M. A., Valle, N. R.-D., & Huang, P. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1957 · Cited by 1,781
“…of stimuli [including growth factors such as IGF-1, hormones, vasoactive peptides such as thrombin, metal ions such as CoCl 2 , H 2 O 2 , and certain NO donors such as S-nitrosoglutathione (GSNO) and NOC-18] are known to stabilize HIF, in part through increase ROS/RNS production (17, 100, 208).”
Hypoxia-Inducible Factor-1 (HIF-1)
Ke, Q., & Costa, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027029 · Cited by 1,646
“The transcription of FIH-1 is independent of the oxygen concentration, and it does not influence HIF-1 stability (Metzen et al., 2003a).”
InfluentialThe role of nitric oxide in tumour progression
Fukumura, D., Kashiwagi, S., & Jain, R. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1910 · Cited by 1,259
“It also impairs normoxic degradation of HIF1α by inhibiting the action of prolyl hydroxylase”
Metadata
- Authors
- Metzen, E., Zhou, J., Jelkmann, W., Fandrey, J., & Brüne, B.
- Affiliations
- University of Lübeck (DE)
- University of Kaiserslautern (DE)
- University of Duisburg-Essen (DE)
- Venue
- Molecular Biology of the Cell
- Published
- 2003-08
- Volume
- 14
- Issue
- 8
- Pages
- 3470-3481
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- PMC
- PMC181582
- OpenAlex
- W2072634616
- Cited by
- 414
- References
- 63
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 10 · 2023: 13 · 2022: 7 · 2021: 22 · 2020: 13 · 2019: 12 · 2018: 9 · 2017: 12 · 2016: 23 · 2015: 19 · 2014: 10 · 2013: 14 · 2012: 17
- FWCI
- 9.57
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Molecular Biology of the Cell (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- European Molecular Biology Laboratory
- University of Oxford
- Deutsche Forschungsgemeinschaft (SFB367, BR999)
- Deutsche Krebshilfe
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- nitric oxide, HIF-1α, prolyl hydroxylase, S-nitrosoglutathione, HIF-1α degradation, ubiquitination, von Hippel-Lindau protein, oxygen-dependent degradation domain, cobalt chloride, hypoxia, protein stability
- MeSH terms
- Cells, Cultured, Humans, Nitric Oxide, Procollagen-Proline Dioxygenase, Protein Binding, Transcription Factors, Transcription, Genetic, Protein Biosynthesis, Cell Hypoxia, Tumor Suppressor Proteins, S-Nitrosoglutathione, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.